Paper30173145
Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma.
Velagapudi S and 6 others. J Lipid Res, 2018. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma. Papers, record 30173145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30173145
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Renal Cell | Major topic |
| Kidney Neoplasms | Major topic |
| Receptors, Scavenger | Major topic |
| Apolipoprotein A-I | |
| Apolipoproteins | |
| Apolipoproteins B | |
| Blotting, Western | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Lipoproteins | |
| RNA, Small Interfering | |
| Real-Time Polymerase Chain Reaction | |
| Vascular Endothelial Growth Factor A |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22,811,413 | The PCSK9 decade. | J Lipid Res | 2012 | https://conductscience.org/library/papers/22811413 | PubMed |
| 2 | 2,052,575 | Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/2052575 | PubMed |
| 3 | 26,334,034 | A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis. | Cardiovasc Res | 2015 | https://conductscience.org/library/papers/26334034 | PubMed |
| 4 | 16,546,443 | Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells. | Biochim Biophys Acta | 2006 | https://conductscience.org/library/papers/16546443 | PubMed |
| 5 | 23,663,736 | Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. | Cell Metab | 2013 | https://conductscience.org/library/papers/23663736 | PubMed |
| 6 | 29,163,190 | SR-BI Mediated Transcytosis of HDL in Brain Microvascular Endothelial Cells Is Independent of Caveolin, Clathrin, and PDZK1. | Front Physiol | 2017 | https://conductscience.org/library/papers/29163190 | PubMed |
| 7 | 25,433,516 | Isolation and epithelial co-culture of mouse renal peritubular endothelial cells. | BMC Cell Biol | 2014 | https://conductscience.org/library/papers/25433516 | PubMed |
| 8 | 19,372,466 | High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1. | Circ Res | 2009 | https://conductscience.org/library/papers/19372466 | PubMed |
| 9 | 23,007,793 | The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma. | J Pathol | 2013 | https://conductscience.org/library/papers/23007793 | PubMed |
| 10 | 21,813,754 | Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. | Sci Transl Med | 2011 | https://conductscience.org/library/papers/21813754 | PubMed |
| 11 | 28,360,088 | VEGF-A Regulates Cellular Localization of SR-BI as Well as Transendothelial Transport of HDL but Not LDL. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28360088 | PubMed |
| 12 | 15,130,918 | Intracellular cholesterol transport. | Arterioscler Thromb Vasc Biol | 2004 | https://conductscience.org/library/papers/15130918 | PubMed |
| 13 | 22,824,167 | Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome. | BMC Cancer | 2012 | https://conductscience.org/library/papers/22824167 | PubMed |
| 14 | 11,431,362 | Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. | Cancer Res | 2001 | https://conductscience.org/library/papers/11431362 | PubMed |
| 15 | 29,357,836 | Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29357836 | PubMed |
| 16 | 23,291,219 | Regulation of erythropoiesis by hypoxia-inducible factors. | Blood Rev | 2013 | https://conductscience.org/library/papers/23291219 | PubMed |
| 17 | 23,433,880 | Renal tumors with clear cells. A review. | Pathol Res Pract | 2013 | https://conductscience.org/library/papers/23433880 | PubMed |
| 18 | 3,681,141 | Abnormal cholesterol metabolism in renal clear cell carcinoma. | J Lipid Res | 1987 | https://conductscience.org/library/papers/3681141 | PubMed |
| 19 | 28,466,781 | Diagnostic and prognostic value of scavenger receptor class B type 1 in clear cell renal cell carcinoma. | Tumour Biol | 2017 | https://conductscience.org/library/papers/28466781 | PubMed |
| 20 | 28,974,560 | Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation. | Mol Cancer Res | 2018 | https://conductscience.org/library/papers/28974560 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,988,996 | Prognostic role of preoperative low density to non-low-density lipoprotein cholesterol ratio in clear cell renal cell carcinoma: A retrospective study. | Cancer Causes Control | 2026 | https://conductscience.org/library/papers/42988996 | PubMed |
| 41,039,547 | Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41039547 | PubMed |
| 40,634,478 | Adaptations of lipid metabolism in low-grade clear cell renal cell carcinoma are linked to cholesteryl ester accumulation. | Sci Rep | 2025 | https://conductscience.org/library/papers/40634478 | PubMed |
| 37,080,216 | [HDL - Quo vadis]. | Dtsch Med Wochenschr | 2023 | https://conductscience.org/library/papers/37080216 | PubMed |
| 35,251,975 | Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential. | Front Oncol | 2022 | https://conductscience.org/library/papers/35251975 | PubMed |
| 34,463,854 | High Density Lipoproteins: Is There a Comeback as a Therapeutic Target? | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/34463854 | PubMed |
| 34,254,531 | Scavenger Receptor BI Induced by HDL From Coronary Heart Disease May Be Related to Atherosclerosis. | Clin Appl Thromb Hemost | 2021 | https://conductscience.org/library/papers/34254531 | PubMed |
| 32,358,065 | Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice. | J Biol Chem | 2020 | https://conductscience.org/library/papers/32358065 | PubMed |
| 31,974,661 | [Characterization of different renal cell carcinoma entities]. | Urologe A | 2020 | https://conductscience.org/library/papers/31974661 | PubMed |
| 31,963,743 | In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31963743 | PubMed |
| 31,779,197 | LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea. | Biomolecules | 2019 | https://conductscience.org/library/papers/31779197 | PubMed |
| 30,823,658 | Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30823658 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30173145
GET https://conductscience.org/api/papers/v1/30173145/references?page=2